第六届海德堡骨髓瘤研讨会会议报告：多发性骨髓瘤诊断与治疗的现状及进展
Meeting report of the 6th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myeloma.
作者信息
Merz Maximilian, Raab Marc S, Goldschmidt Hartmut, Hillengass Jens
机构信息
Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Max Eder Group Experimental Therapies for Hematologic Malignancies, German Cancer Research Center, Heidelberg, Germany.
出版信息
J Cancer Res Clin Oncol. 2017 Dec;143(12):2521-2526. doi: 10.1007/s00432-017-2463-x. Epub 2017 Jun 26.
PURPOSE
The 6th Heidelberg Myeloma Workshop was held on May 5th and 6th, 2017 in the lecture hall of the University Hospital Heidelberg.
METHODS AND RESULTS
Main topics of the meeting were (1) biology and genomics of multiple myeloma, (2) diagnostics and prognostic factors, (3) role of immunotherapy in multiple myeloma, as well as (4) therapy of multiple myeloma-drugs and treatment strategies.
CONCLUSION
The landscape for the treatment of newly diagnosed and relapsed disease has significantly changed since the last Heidelberg Myeloma Workshop in 2015. Updates on the current developments were presented at the meeting.
目的
第六届海德堡骨髓瘤研讨会于2017年5月5日至6日在海德堡大学医院的报告厅举行。
方法与结果
会议的主要议题包括：（1）多发性骨髓瘤的生物学与基因组学；（2）诊断与预后因素；（3）免疫疗法在多发性骨髓瘤中的作用；以及（4）多发性骨髓瘤的治疗——药物与治疗策略。
结论
自2015年上一届海德堡骨髓瘤研讨会以来，新诊断和复发疾病的治疗格局已发生显著变化。会议上介绍了当前进展的最新情况。
Zotero 插件